{"filings":[{"id":2033236,"accession_number":"0001628280-26-052113","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-08-04T10:33:40+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 net sales $4.2B, flat organic; adjusted EPS $1.80, +10.4%; China disruption","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B, up 0.6%; organic sales flat; adjusted gross margin 38.8%, up 190 bps YoY.","Adjusted EPS from continuing ops $1.80, up 10.4%; adjusted EPS attributable to K-C $2.12, up 10.4%.","China social media disruption negatively impacted diaper sales in Q2; expected to further impact near-term sales and profits.","Strategic updates: Arbex JV with Suzano launched; Kenvue acquisition on track for year-end close; alternative fibers pilot plant announced.","CEO cites discrete headwinds that will moderate 2026 growth and earnings potential; no specific guidance numbers provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":442960,"accession_number":"0001628280-26-035124","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-05-14T20:16:55+00:00","items":["5.07"],"status":"ready","headline":"Kimberly-Clark elects all 13 directors; shareholder proposal for independent chair fails","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 13 management director nominees elected with votes ranging from 229.4M to 240.7M for each.","Ratification of Deloitte & Touche as 2026 auditor passed with 271.5M for vs 17.3M against.","Advisory vote on named executive officer compensation approved with 227.4M for, 14.6M against.","Stockholder proposal requiring an independent board chair defeated (81.7M for, 159.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98240,"accession_number":"0001628280-26-030566","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark Controller Andrew Scribner to Depart; CFO Nelson Urdaneta to Assume Interim Role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner, Vice President and Controller, notified of departure effective May 22, 2026 to pursue other opportunities.","Senior Vice President and CFO Nelson Urdaneta will serve as principal accounting officer on an interim basis starting May 22, 2026.","Mr. Urdaneta will continue his current CFO duties while assuming the additional interim controller responsibilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98239,"accession_number":"0001628280-26-027718","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 2026: Net sales $4.2B (+2.7%), adj. EPS attributable $1.97 (+2.1%), reaffirms 2026 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B, up 2.7% (organic +2.5%); volume/mix +3% offset by pricing -0.5%.","Adjusted EPS from continuing ops $1.60 (-1.2%) on higher tax rate; adjusted EPS attributable $1.97 (+2.1%) including discontinued ops.","Adjusted operating profit $732M (+3.7%) on productivity savings; GAAP gross margin 36.8%, adjusted 37.9% (-60bps).","Includes $120M insurance settlement benefit and $99M charges for Transformation & Kenvue acquisition costs.","Reaffirmed 2026 outlook; CEO cites momentum and Kenvue acquisition as 'generational value creation opportunity.'"],"consensus_eps_estimate":null,"consensus_eps_actual":2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":4163000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113584,"accession_number":"0001104659-26-008005","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.07","7.01","9.01"],"status":"ready","headline":"Kimberly-Clark and Kenvue shareholders overwhelmingly approve acquisition; deal expected H2 2026","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Approximately 96% of Kimberly-Clark shares present voted to approve share issuance related to the acquisition.","Approximately 99% of Kenvue shares voted to adopt merger agreement, representing ~77% of all outstanding shares.","Transaction expected to close in second half of 2026, subject to regulatory approvals and customary conditions.","Kimberly-Clark CEO cites milestone in creating global health and wellness leader; integration planning underway."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113583,"accession_number":"0001628280-26-003514","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"KMB reports Q4 adjusted EPS $1.86 (+24% YoY); organic sales +2.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $4.1B, down 0.6% (organic +2.1%); full-year adjusted EPS $7.53, up 3.2%.","Adjusted Q4 operating profit $629M, +13.1% YoY; adjusted gross margin 37.0% in line with prior year.","Personal Care segments: NA organic sales +0.8%, IPC +4.5% in Q4; volume-plus-mix driven growth.","Company announces acquisition of Kenvue as next step in transformation, citing strong integration progress."],"consensus_eps_estimate":null,"consensus_eps_actual":6.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":16447000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":113582,"accession_number":"0001104659-26-004634","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2026-01-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Kimberly-Clark supplements proxy disclosures in response to stockholder lawsuits over Kenvue merger","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Four lawsuits filed Dec 2025–Jan 2026 by Kenvue stockholders; one Delaware suit by K‑C stockholder.","Supplement adds details on strategic review committee formed June 30, 2025, and NDA terms with K‑C.","K‑C engaged Gibson Dunn for product liability due diligence; Kirkland disclosed Kenvue <1% of revenue.","J.P. Morgan expects ~$23.4M financing fees; aggregate fees from Kenvue $24M, from K‑C $11M.","Centerview updated DCF analysis implying K‑C equity value range of $119.14–$141.25 per share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129982,"accession_number":"0001628280-25-055209","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark recasts prior financials; filing truncated, lacks details","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Item 8.01 filed to recast certain annual report financial information and related disclosures.","XBRL tags indicate recast covers fiscal years 2022-2024, including 2024 Transformation Initiative and sale of KC Professional PPE business.","Segments noted: North America and International Personal Care; Thinx and Brazil tissue sale referenced.","Filing text cuts off mid-sentence; no specific recast numbers or reasons provided.","Investor should await complete filing for material impact of restated figures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129981,"accession_number":"0001628280-25-050635","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark CDTO Zackery Hicks to depart March 31, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Zackery Hicks, Chief Digital and Technology Officer, will leave effective March 31, 2026 to pursue other opportunities.","Hicks will receive severance benefits consistent with the company's Severance Pay Plan.","No replacement or interim officer has been announced as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129980,"accession_number":"0001104659-25-105220","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Kimberly-Clark to acquire Kenvue in stock-and-cash deal; $7.7B bridge facility arranged","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Each Kenvue share to receive 0.14625 K-C shares + $3.50 cash; boards of both companies unanimously approved.","K-C secures $7.7B bridge loan commitment from JPMorgan to fund cash consideration and related expenses.","Termination fee of $1.136B payable under certain conditions; deal expected to close by Nov 2026 (possible extension to May 2027).","Post-closing, K-C Board will include three Kenvue designees; Kenvue equity awards converted to K-C awards.","Transaction subject to stockholder approvals, HSR and foreign antitrust clearances, and other customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":129979,"accession_number":"0001628280-25-047278","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3: net sales $4.2B flat, organic +2.5%, adj EPS $1.82 in line, margin down 170bps","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B flat YoY; organic sales +2.5% on 2.4% volume growth.","Reported EPS $1.34; adjusted EPS $1.82 broadly in line with prior year.","Adjusted gross margin 36.8%, down 170bps due to tariff costs and price investments.","Effective tax rate on adjusted basis 26.5% vs 21.5% prior, impacted by OBBBA.","YTD organic sales +1.6%; adjusted EPS $5.67, down 2.2% including FX headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":4.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":12367000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146570,"accession_number":"0000055785-25-000076","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimb Q2 organic sales +3.9%; vol growth 5%; raised 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $4.2B, down 1.6% total; organic sales +3.9% on 5% volume growth, highest in 5 years.","Reported diluted EPS $1.53; adjusted EPS $1.92, down 2.0% YoY, including currency headwinds.","Adjusted gross margin 36.9%, down 180 bps due to pricing investments and tariff costs, offset by productivity.","Full-year 2025 outlook raised; management cites strong execution of Powering Care transformation.","Personal Care organic +3.3%, North America +4.3%, International Professional & Consumer +0.4%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":8217000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146569,"accession_number":"0000055785-25-000071","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Kimberly-Clark files supplemental financials for IFP joint venture with Suzano","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Suzano acquires 51% of IFP joint venture for ~$1.7B at closing; K-C retains 49%.","IFP Business reclassified as discontinued operations effective Q2 fiscal 2025.","Supplemental historical financials provided in Exhibit 99.1 to aid year-over-year comparisons.","No specific financial figures from the exhibit are available in this filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164949,"accession_number":"0001104659-25-056662","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Kimberly-Clark to sell 51% of IFP business to Suzano for ~$1.7B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["IFP contributed ~$3.3B net sales in 2024; 22 plants, ~9,000 employees, 70+ countries.","KMB retains 49% stake; Suzano gets call option on remaining stake under agreed framework.","Deal expected to close mid-2026; first-full-year diluted EPS by $0.30–0.40.","KMB expects to return net cash proceeds to shareholders via share repurchases.","Sharpen focus on higher-growth personal care and North America tissue categories."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164948,"accession_number":"0000055785-25-000051","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["3.01","5.03","7.01","9.01"],"status":"ready","headline":"Kimberly-Clark to transfer stock listing from NYSE to Nasdaq effective May 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Common stock to cease trading on NYSE at close on May 29, 2025; trading begins on Nasdaq Global Select on May 30, 2025 under symbol 'KMB'.","Board amended By-Laws to remove references to NYSE rules, effective upon Nasdaq listing.","Transfer is voluntary; ticker symbol KMB unchanged.","Forward-looking statements caution about risks of delays or market disruptions during transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164947,"accession_number":"0000055785-25-000044","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark promotes Russ Torres to President and COO, effective May 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Torres previously President, North America; now oversees day-to-day operations of all business segments and global functions.","Base salary $975,000, target bonus 125%, equity grants: 19,866 PSUs and 13,244 RSUs.","Kurt Laufer named Interim President, North America; permanent successor search underway.","Jeffrey Melucci elected Chief Strategy, Business Development and Administrative Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164944,"accession_number":"0000055785-25-000045","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K/A","filed_at":"2025-05-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Scribner receives 2,118 performance and 2,118 time-vested RSUs, $535K salary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner's base salary set at $535,000 per year; effective June 1, 2025 as VP and Controller.","Target annual bonus of 55% of base salary under company performance-based incentive plan.","Long-term incentive award of 2,118 performance-based RSUs and 2,118 time-vested RSUs granted.","Eligible for supplemental 401(k) plan and other employee benefit plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164946,"accession_number":"0000055785-25-000041","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"All 13 Kimberly-Clark director nominees elected; Deloitte ratified; say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 13 management director nominees elected; Michael D. Hsu received 15.9M votes against (6% of votes cast).","Ratification of Deloitte & Touche as 2025 auditor passed with 267.2M for, 20.0M against (7% against).","Advisory vote on named executive officer compensation approved with 226.8M for, 17.4M against (7% against).","Broker non-votes of 41.9M shares on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":164945,"accession_number":"0000055785-25-000034","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 net sales $4.8B (-6.0%); adjusted EPS $1.93 (-4.0%); cuts full-year outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $4.8B, down 6.0% YoY; organic sales -1.6% (price -1.5%, volume/mix flat).","Adjusted EPS $1.93, down 4.0% vs prior year; reported EPS $1.70 includes $0.23 Transformation charges.","Adjusted gross margin 36.9%, down 20bps; adjusted operating profit $844M, down 6.0%.","Full-year 2025 outlook lowered to reflect potential incremental costs from geopolitical uncertainty.","Transformation Initiative charges in Q1: $75M ($0.23 EPS) vs $45M ($0.10) in prior year."],"consensus_eps_estimate":null,"consensus_eps_actual":1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":4840000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182662,"accession_number":"0000055785-25-000008","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kimberly-Clark names Andrew Scribner VP and Controller, replacing retiring Andrew Drexler","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andrew Scribner elected VP and Controller, effective June 1, 2025; succeeds Andrew S. Drexler.","Drexler will assume a transitional role until retirement on June 6, 2025.","Scribner previously CFO of Kimberly-Clark North America since Jan 2023; prior roles at Gap Inc. and Kraft Heinz.","Compensation for Scribner's new role not yet determined; to be disclosed in an 8-K amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":182661,"accession_number":"0000055785-25-000005","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2025-01-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q4 organic sales up 2.3%; FY 2024 adjusted EPS $7.30, up 11.1%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $4.9B (-0.8% total); organic sales grew 2.3% with volume up 1.5%.","Q4 adjusted EPS $1.50, down 0.7% YoY; FY 2024 adjusted EPS $7.30, up 11.1%.","Q4 adjusted gross margin 35.4% (+50 bps); FY adjusted gross margin 36.5% (+200 bps).","FY 2024 adjusted operating profit $3.2B, up 9.4% YoY despite 6.2 ppt currency headwind.","2025 outlook reflects continued organic growth and operating momentum as transformation progresses."],"consensus_eps_estimate":null,"consensus_eps_actual":7.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":20058000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199237,"accession_number":"0000055785-24-000107","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark reorganizes reportable segments effective Q4 2024; provides recast historical data","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New segments: North America (NA), International Personal Care (IPC), and International Family Care and Professional (IFP).","Replaces former segments: Personal Care, Consumer Tissue, and K-C Professional.","Supplemental recast financials provided for quarters back to Q1 2023 and years 2021-2023.","Segment profitability measure now includes effects of highly inflationary currency adjustments.","No impact on consolidated financial results; change improves supply chain and overhead efficiency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199236,"accession_number":"0000055785-24-000098","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark elects Joseph Romanelli to board of directors, effective immediately","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Romanelli, 51, appointed as independent director and to the Audit Committee; board expands from 12 to 13 members.","He serves as President of Human Health International for Merck & Co., Inc. (MSD).","Romanelli brings global leadership experience in biopharmaceuticals and international markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199235,"accession_number":"0000055785-24-000091","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3 adj. EPS $1.83 (+5%), organic sales +1%, net sales down 4% on FX and divestitures","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $5.0B (-4% reported); organic sales +1% (price +1%, volume/mix flat).","Adjusted EPS $1.83 (+5% YoY) with $0.07 FX headwind; GAAP EPS $2.69 includes $1.34 gain from PPE divestiture.","Adjusted operating profit +5%; adjusted gross margin 36.7% (+90 bps) on productivity.","Personal Care organic +3%, Consumer Tissue -1%, K-C Professional -1% (organic).","2024 outlook: organic sales growth revised to 3%-4% (from mid-single digit); profit outlook reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":6.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":15130000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215274,"accession_number":"0000055785-24-000081","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 adj EPS $1.96 (+19% YoY); raises 2024 profit outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $5.0B (organic +4%), reported EPS $1.61, adjusted EPS $1.96 up 19%.","Adjusted operating profit +16%; adjusted gross margin 36.9% (+290 bps YoY).","Personal Care organic +8% (North America +5%, D&E +15%), Consumer Tissue -2%, KCP flat.","2024 outlook raised: adj operating profit and EPS now expected mid-to-high teens constant-currency growth (from low-teens).","YTD operating cash flow $1.5B, returned $965M via dividends and buybacks."],"consensus_eps_estimate":null,"consensus_eps_actual":3.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":10178000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234589,"accession_number":"0000055785-24-000059","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Kimberly-Clark shareholders approve charter amendment limiting officer liability","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved Amended and Restated Certificate of Incorporation to limit personal liability of certain officers for breaches of fiduciary duty of care (not loyalty).","All 12 director nominees elected; Deloitte & Touche ratified as independent auditor for 2024.","Advisory vote on executive compensation approved: ~221.7M for, ~23.5M against.","Charter amendment also includes technical changes; effective May 2, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":234588,"accession_number":"0000055785-24-000053","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 adj EPS $2.01 (+20% YoY); raises FY2024 organic sales and EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net sales $5.1B, organic +6% driven by price (+4%), volume (+1%), mix (+1%).","Gross margin 37.1%, up 390 bps YoY.","Adj EPS $2.01, up 20% YoY; includes $0.21 FX headwind.","Raises 2024 outlook: organic sales now mid-single digits (prev low-to-mid), adj EPS growth low-teens (prev high-single).","Personal Care organic +10%, Consumer Tissue flat, KCP organic +2%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":5149000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252452,"accession_number":"0000055785-24-000045","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-03-27T23:59:59+00:00","items":["2.05","7.01","9.01"],"status":"ready","headline":"Kimberly-Clark announces global transformation initiative; expects $1.5B pre-tax charges through 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approves reorganization into three new segments (North America, IPC, IFP) by end of 2024.","Expects cumulative pre-tax charges of ~$1.5B (50% cash) and ~$800M capital spending through Dec 2026.","Targets long-term adjusted EPS growth mid-to-high single digits; free cash flow ≥$2B annually.","Aims to be 100% natural forest free across product portfolio, more than halfway by 2030.","Reaffirms 2024 outlook: low-to-mid single-digit organic sales growth, high single-digit adj. EPS growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252451,"accession_number":"0000055785-24-000011","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-01-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark names Grant McGee SVP & General Counsel; Melucci becomes Chief Business and Transformation Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jeffrey Melucci elected Chief Business and Transformation Officer, effective immediately.","Grant McGee appointed SVP and General Counsel, effective Feb 1, 2024, reporting to Melucci.","McGee returns from American Airlines, previously at Kimberly-Clark 2015–2022.","McGee will become a member of Kimberly-Clark's executive leadership team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":252450,"accession_number":"0000055785-24-000006","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2024-01-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q4 organic sales +3%, FY2023 adj EPS $6.57 (+17% YoY); guides 2024 growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $5.0B in line YoY; organic sales +3% from price (+2%) and mix (+1%).","Adjusted EPS $1.51, down 2% on hyperinflation and taxes, offset by gross profit expansion.","Full-year 2023 net sales $20.4B (+1%); organic sales +5%; adjusted EPS $6.57, up 17% YoY.","2024 outlook: organic net sales +low-to-mid single digit; constant-currency adj operating profit +high single to low double digit.","Plans Investor Day in late March to detail strategic priorities and long-term financial algorithm."],"consensus_eps_estimate":null,"consensus_eps_actual":5.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":20431000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":269965,"accession_number":"0000055785-23-000061","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-10-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3 net sales $5.1B, organic sales +5%; raises FY2023 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $5.1B (+2% total, +5% organic), driven by 5% price and 1% favorable mix; volume -1%.","Gross margin 35.8% (+530 bps YoY), restored to pre-pandemic level; adjusted EPS $1.74 (+24% YoY).","Personal Care organic sales +7%, Consumer Tissue +2%, K-C Professional +4%; all segments improved margins.","2023 outlook raised: organic growth 4%-5% (prev 3%-5%), adjusted EPS growth 15%-17% (prev 10%-14%).","Year-to-date cash from ops $2.3B vs $1.7B; $1.3B returned to shareholders via dividends and buybacks."],"consensus_eps_estimate":null,"consensus_eps_actual":3.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":15461000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286942,"accession_number":"0000055785-23-000057","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-09-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark elects Deeptha Khanna to board, board increases to 13","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Deeptha Khanna elected as independent director effective September 13, 2023.","Board size increased from 12 to 13 members; Khanna appointed to Audit Committee.","Khanna is EVP & Chief Business Leader, Personal Health at Royal Philips.","Previously held leadership roles at Johnson & Johnson and Procter & Gamble."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286941,"accession_number":"0000055785-23-000053","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-07-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 organic sales +5%, adj. EPS $1.65 (+23%); raises annual outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $5.1B (+1%), organic sales +5% driven by +9% price/mix offset by -3% volume.","Diluted EPS $0.30 includes $1.36/share impairment charge; adjusted EPS $1.65 vs $1.34 prior year.","Gross margin 33.7% (+350 bps); adjusted gross margin 34.0% (+380 bps) on net revenue gains and productivity.","Full-year 2023 outlook raised: organic sales growth 3%-5%, adjusted EPS growth 10%-14% (prior 6%-10%).","Completed sale of Brazil tissue assets in June; year-to-date cash from operations $1.4B vs $944M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":10329000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306954,"accession_number":"0000055785-23-000027","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 organic sales +5%; raises 2023 EPS growth outlook to 6-10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $5.2B (+2% reported, +5% organic); diluted EPS $1.67 (+8% reported, +24% adjusted).","Gross margin 33.2% (+340 bps YoY); operating profit $787M, +25% adjusted.","Personal Care organic +3%, Consumer Tissue +7%, K-C Professional +11%.","2023 outlook raised: EPS growth 6-10% vs 2-6% prior; operating profit up low double digits.","Cash from operations $613M (vs $204M); capex $201M; $34M share repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":1.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":5195000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":306953,"accession_number":"0000055785-23-000016","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-04-20T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Kimberly-Clark stockholders elect all 12 director nominees, ratify Deloitte as auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All director nominees elected; Michael D. Hsu received ~95% of votes cast in favor.","Deloitte & Touche ratified as independent auditor with ~96% votes for (280M for, 11.7M against).","Advisory say-on-pay approved with ~94% votes for, 5.6% against, excluding broker non-votes.","Stockholders favored annual advisory votes on executive compensation; Board adopts annual frequency."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326034,"accession_number":"0001104659-23-022818","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-02-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark issues $350M of 4.500% Notes due 2033","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $350,000,000 aggregate principal amount of 4.500% Notes due February 16, 2033.","Underwriting agreement dated Feb 13, 2023 with HSBC, J.P. Morgan, Morgan Stanley, and RBC as representatives.","Notes issued under existing shelf registration (File No. 333-262635) and Tenth Supplemental Indenture dated Feb 16, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":326033,"accession_number":"0000055785-23-000005","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2023-01-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q4 adjusted EPS $1.54 (+18% YoY); guides 2023 EPS growth 2-6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $5.0B flat YoY; organic sales +5% on 10% price increase offset by 7% volume decline.","Full-year adjusted EPS $5.63 (-9% YoY); Q4 adjusted EPS $1.54 beats $1.30 prior year.","2023 outlook: organic sales +2-4%, EPS +2-6% vs 2022 adjusted; input costs expected +$200-300M.","Board approves 1.7% dividend increase to $1.18/quarter, marking 51st consecutive annual hike.","Personal Care segment sales -3% due to private label exit; KCP sales +11% led by 20% price increase."],"consensus_eps_estimate":null,"consensus_eps_actual":5.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":20175000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":343754,"accession_number":"0000055785-22-000073","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-10-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3 adj. EPS $1.40 (-14% YoY); organic sales +5%; guidance maintained at lower end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $5.1B, +1% reported; organic sales +5% on 9% price, 1% mix, -5% volume; FX hurt 4%.","Adj. EPS $1.40 vs $1.62 YoY; GAAP EPS $1.38; input cost headwind $360M partially offset by $80M FORCE savings.","Personal Care sales -1% (volumes -7%), Consumer Tissue +2%, K-C Professional +5%; all segments raised prices.","FY2022 outlook: organic sales growth 5-7% (unchanged); adj. EPS at lower end of $5.60-$6.00; capex trimmed to $0.9-1.0B.","CEO cites sequential margin improvement; currency now seen as 3-4% sales drag (was 3%) and mid-to-high single-digit OP impact."],"consensus_eps_estimate":null,"consensus_eps_actual":4.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":15211000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360260,"accession_number":"0000055785-22-000060","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-09-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark adopts Voluntary Deferred Compensation Plan for key employees","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Eligible employees can defer up to 50% of base salary and up to 90% of annual performance bonus.","No employer match or similar contributions under the Plan.","Distributions available in lump sum or installments upon specified events; a rabbi trust may be established.","Plan effective January 1, 2023; administered by Benefits Administration Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":360259,"accession_number":"0000055785-22-000053","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-07-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 2022 net sales $5.1B, organic sales up 9%, raises organic growth outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Second quarter net sales of $5.1 billion increased 7% year-over-year; organic sales rose 9%.","Adjusted earnings per share of $1.34, down 9% from $1.47 in Q2 2021.","Full-year 2022 organic sales growth outlook raised to 5-7% (prior 4-6%); adjusted EPS guidance maintained at $5.60-$6.00.","Input cost inflation for 2022 expected to be $1.4 to $1.6 billion, higher than prior estimate of $1.1-$1.3 billion.","Personal Care segment sales up 8% to $2.7 billion; operating profit increased 3%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":10158000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379270,"accession_number":"0000055785-22-000038","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-04-27T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Kimberly-Clark stockholders re-elect all 13 directors, ratify Deloitte as auditor, approve say-on-pay","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 13 director nominees elected with substantial support; Michael D. White received most votes for (242.9M).","Ratification of Deloitte & Touche LLP as independent auditor for 2022: 276.6M for, 13.5M against.","Advisory approval of named executive officer compensation passed: 228.4M for, 14.9M against.","Broker non-votes totaled 46.2M on director elections and say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":379269,"accession_number":"0000055785-22-000032","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q1 net sales $5.1B (+7%), adj EPS $1.35 (-25% YoY), raises organic sales growth guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $5.1B, +7% YoY; organic sales +10% (price +6%, volume +2%, mix +2%).","Adj EPS $1.35 vs $1.80 YoY (-25%); GAAP EPS $1.55 vs $1.72.","FY2022 organic sales growth guidance raised to 4-6% from 3-4%; adj EPS outlook $5.60-$6.00.","Q1 input cost inflation $470M; full-year cost headwind raised to $1.1-1.3B (prev. $750-900M).","Segment op profit declines: Personal Care -1%, Consumer Tissue -36%, KCP -29%."],"consensus_eps_estimate":null,"consensus_eps_actual":1.55,"consensus_revenue_estimate":null,"consensus_revenue_actual":5095000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397466,"accession_number":"0001104659-22-036329","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-03-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Kimberly-Clark names Nelson Urdaneta CFO; Maria Henry to retire","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nelson Urdaneta appointed SVP & CFO effective April 22, 2022.","Maria Henry will retire and serve in advisory capacity until Sept 1, 2022.","Urdaneta joins from Mondelēz where he was SVP, Treasurer and previously Corporate Controller.","Compensation: base salary $775k, target bonus 100%, LTI target $2.2M, sign-on cash $250k and RSUs $1.25M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397465,"accession_number":"0000055785-22-000015","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-03-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark nominates former HHS Secretary Sylvia Burwell to board; Ian Read to retire","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sylvia M. Burwell nominated for election to board at April 27, 2022 annual meeting.","Ian C. Read will not stand for re-election; his term ends at the annual meeting.","Burwell served as U.S. HHS Secretary (2014-2017) and American University president.","Board size would remain at 13 members if Burwell is elected.","Read was Lead Director from 2017 to 2020; Hsu thanked him for strategic leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":397464,"accession_number":"0000055785-22-000006","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2022-01-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q4 adjusted EPS $1.30, down 23% YoY; 2022 guidance EPS $5.60-$6.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2021 net sales $5.0B (+3% YoY); organic sales +3%, full-year net sales $19.4B (+2%).","Q4 2021 GAAP diluted EPS $1.06; adjusted EPS $1.30 vs $1.69 in Q4 2020 (-23%).","Full-year 2021 adjusted EPS $6.18, down 20% YoY; within guidance of $6.05-$6.25.","2022 outlook: organic sales +3-4%, GAAP EPS $5.60-$6.00; input cost inflation expected $750-$900M.","Dividend increased 1.8% to $1.16/quarter, marking 50th consecutive annual increase."],"consensus_eps_estimate":null,"consensus_eps_actual":5.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":19440000000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416441,"accession_number":"0001104659-21-132990","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2021-11-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kimberly-Clark issues $600M of 2.000% Notes due 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M aggregate principal of 2.000% Notes due November 2, 2031.","Underwriting agreement with BBVA, Goldman Sachs, J.P. Morgan, RBC as representatives.","Notes issued under shelf registration; Ninth Supplemental Indenture dated Nov 2, 2021.","Eighth Supplemental Indenture appoints U.S. Bank as successor trustee for future securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":416440,"accession_number":"0000055785-21-000088","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2021-10-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q3 adjusted EPS $1.62, misses; lowers FY2021 guidance on inflation","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $5.0B (+7% YoY); organic sales +4%; adjusted EPS $1.62 vs $1.72 YoY.","GAAP diluted EPS $1.39; adjusted operating profit $745M, down from $806M.","FY2021 adjusted EPS guidance lowered to $6.05-$6.25 from $6.65-$6.90.","Input cost inflation now expected $1.4-$1.5B, up from prior $1.2-$1.3B.","Organic sales now seen declining 1-2% vs prior 0-2% decline; share repurchases at low end."],"consensus_eps_estimate":null,"consensus_eps_actual":4.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":14475000000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":434016,"accession_number":"0000055785-21-000079","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2021-09-15T23:59:59+00:00","items":["5.01","9.01"],"status":"ready","headline":"Kimberly-Clark elects Deirdre Mahlan and Jaime Ramirez to board, increasing size to 13","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Elected Deirdre Mahlan (former President Diageo North America) and Jaime Ramirez (EVP, President Global Tools & Storage at Stanley Black & Decker) as independent directors, effective immediately.","Both appointed to Audit Committee; board size increased from 11 to 13 members.","Mahlan brings CPG and finance experience; Ramirez brings international and emerging markets perspective.","Compensation follows standard outside director programs described in 2021 proxy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":434015,"accession_number":"0000055785-21-000072","cik":55785,"company_name":"KIMBERLY CLARK CORP","ticker":"KMB","form_type":"8-K","filed_at":"2021-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Kimberly-Clark Q2 adjusted EPS $1.47 vs $2.20 YoY; cuts full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $4.7B (+2% YoY); organic sales fell 3% on volume decline of 4%.","Adjusted EPS $1.47 (down 33% YoY); GAAP EPS $1.19 (down 40% YoY).","FY2021 adjusted EPS guidance cut to $6.65-$6.90 from prior $7.30-$7.55.","Input cost inflation now seen at $1.2-$1.3B (prior $0.9-$1.05B) due to pulp and polymers.","Consumer tissue volumes sank 15% as North American destocking continued."],"consensus_eps_estimate":null,"consensus_eps_actual":2.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":9465000000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":33253781943.85887,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}